Search

Jennie Powell Mather

from Millbrae, CA
Age ~76
Get Report
Also known as:
Jennie P Mather, Jennie Dr Mather, Jennie Pt Mather, Jennie P Matter, Jp Mather
Phone and address:
269 La Prenda, Millbrae, CA 94030
(650) 697-2098
Connected to:
Alan R Mather, 59Albert W Mather, 97Alexa R Mather, 36Angie S Mather, 72Eric P Mather, 49Eugene J Mather, 86Heather M Mather, 35Janet Mather, 72Jason L Mather, 48Jennifer Mather, 55

Jennie Mather Phones & Addresses

  • 269 La Prenda, Millbrae, CA 94030 (650) 697-2098
  • South San Francisco, CA
  • San Carlos, CA
  • Rhineland, MO
  • Mountain View, CA
  • 269 La Prenda, Millbrae, CA 94030 (650) 888-2924

Work

Position: Food Preparation and Serving Related Occupations

Education

Degree: Associate degree or higher

Emails

b***[email protected]

Resumes

Resumes

Jennie Mather Photo 1

Director And Chief Scientific Advisor

Location:
269 La Prenda, Millbrae, CA 94030
Industry:
Biotechnology
Work:
Kairui Biotech
Director and Chief Scientific Advisor
Canfel Therapeutics
C0-Founder and Chief Executive Officer
Macrogenics, Inc. Jul 2008 - Dec 2012
Senior Vice President, Research
Raven Biotechnologies 2006 - 2008
Founder President and Chief Strategy Officer
Raven Biotechnologies 1999 - 2006
Founder President and Chief Executive Officer
Education:
Uc San Diego 1975 - 1978
Uc San Diego 1970 - 1975
Doctorates, Doctor of Philosophy, Biology Brandeis University 1966 - 1969
Bachelors, Bachelor of Arts, Biology
Skills:
Biotechnology
Cell Culture
Protein Chemistry
Biopharmaceuticals
Cancer
Drug Discovery
Cell Biology
Stem Cells
Immunology
Clinical Trials
Antibodies
Drug Development
Genomics
Technology Transfer
Life Sciences
Lifesciences
Clinical Development
Oncology
Molecular Biology
Stem Cell Research
Interests:
Exercise
Home Improvement
Reading
Shooting
Gourmet Cooking
Sports
Home Decoration
Diy
Cooking
Electronics
Outdoors
Crafts
Music
Movies
Collecting
Kids
Woodwork
Travel
Investing
Traveling
Languages:
English
Jennie Mather Photo 2

Senior Vice President At Macrogenics

Position:
Senior Vice President at MacroGenics
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
MacroGenics
Senior Vice President
BTI Singapore 2004 - 2010
SAB Member
Raven biotechnologies, inc Jan 1999 - Jul 2008
Founder and CEO / CSO
Genentech Jun 1984 - Jan 1999
Staff Scientist
Population Council 1979 - 1984
Scientist
Education:
University of California, San Diego 1970 - 1975
PhD, Biology Brandeis University 1966 - 1969
BA, Biology

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jennie P. Mather
Director
Raven Biotechnologies, Inc
Commercial Physical Research · Research & Development in Biotechnology
1 Corporate Dr, South San Francisco, CA 94080
(650) 624-2600, (650) 624-2780
Jennie Mather
Principal
Wallace and Co
Investment Advice
1 Embarcadero Ctr STE 760, San Francisco, CA 94111
(415) 576-1111
Jennie Mather
Founder President Chief Scientific Officer And Director
Zosano Pharma
Pharmaceuticals · Ret Misc Merchandise · Noncommercial Research Organization
34790 Ardentech Ct, Fremont, CA 94555
(510) 745-7088, (510) 739-3003

Publications

Isbn (Books And Publications)

Peptide Growth Factors

Author

Jennie P. Mather

ISBN #

0121820998

Animal Cell Culture Methods

Author

Jennie P. Mather

ISBN #

0124800408

Mammalian Cell Culture: The Use of Serum-Free Hormone-Supplemented Media

Author

Jennie P. Mather

ISBN #

0306415844

Introduction to Cell and Tissue Culture: Theory and Technique

Author

Jennie P. Mather

ISBN #

0306458594

Us Patents

Method For Culturing Recombinant Cells

US Patent:
6399331, Jun 4, 2002
Filed:
Nov 30, 2000
Appl. No.:
09/728342
Inventors:
Jennie P Mather - Millbrae CA
Axel Ullrich - Portola Valley CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C12P 2102
US Classification:
435 691, 435358
Abstract:
A method for culturing a recombinant host cell comprising: determining a polypeptide factor for a polypeptide factor-dependent host cell; transforming said host cell with nucleic acid encoding said polypeptide factor; transforming the host cell with nucleic acid encoding a desired protein; and, culturing the transformed host cells in a medium lacking the polypeptide factor.

Cell Arrays And The Uses Thereof

US Patent:
6406840, Jun 18, 2002
Filed:
Dec 17, 1999
Appl. No.:
09/466011
Inventors:
Ronghao Li - La Jolla CA
Jennie P. Mather - Millbrae CA
Assignee:
bioMosaic Systems, Inc. - South San Francisco CA
International Classification:
C12N 502
US Classification:
435 13, 435325, 435243
Abstract:
The present invention provides cell arrays comprising a plurality of tubes containing populations of cells that are immobilized therein. The arrays are particularly useful for conducting comparative cell-based analyses. Specifically, the subject arrays allow protein-protein interactions to be studied in multiple types of cell simultaneously. The arrays also support simultaneous detection of the differential expression of a target polynucleotide in a multiplicity of cell types derived from multiple subjects. The subject arrays further permit high throughput screening for candidate modulators of a signal transduction pathway of interest. Further provided by the invention are kits, computer-implemented methods and systems for conducting the comparative cell-based analyses.

Human Mã¼Llerian Duct-Derived Epithelial Cells And Methods Of Isolation And Uses Thereof

US Patent:
6416999, Jul 9, 2002
Filed:
Apr 7, 2000
Appl. No.:
09/545435
Inventors:
Jennie Powell Mather - Millbrae CA
Assignee:
Raven Biotechnologies, Inc. - South San Francisco CA
International Classification:
C12N 508
US Classification:
435366, 435325, 435363, 435378, 435383, 435405
Abstract:
This invention discloses a substantially pure population of human MÃllerian duct-derived epithelial cells and methods of isolating and culturing the MÃllerian duct-derived epithelial cells. By carefully manipulating the microenvironment in which the MÃllerian duct-derived epithelial cells are grown, multiple passages are attainable wherein the MÃillerian duct-derived epithelial cells are capable of becoming uterine, cervical, vaginal, and oviductal cells. In addition, several uses of human MÃllerian duct-derived epithelial cells and cells differentiating therefrom are disclosed herein.

Human Pancreatic Epithelial Progenitor Cells And Methods Of Isolation And Use Thereof

US Patent:
6436704, Aug 20, 2002
Filed:
Apr 10, 2000
Appl. No.:
09/546577
Inventors:
Penelope E. Roberts - Millbrae CA
Jennie Powell Mather - Millbrae CA
Assignee:
Raven Biotechnologies, Inc. - South San Francisco CA
International Classification:
C12N 500
US Classification:
435366, 435325, 435363, 435378, 435383, 435405
Abstract:
The invention discloses a substantially pure population of human pancreatic progenitor cells and methods of isolating and culturing the pancreatic progenitor cells. By carefully manipulating the microenvironment of the pancreatic progenitor cells, multiple passages are attainable wherein the pancreatic progenitor cells do not senesce and furthermore, are capable of becoming functional exocrine or endocrine cells. In addition, several methods of use of human pancreatic progenitor cells are disclosed herein.

Receptor Polypeptides And Their Production And Uses

US Patent:
6455262, Sep 24, 2002
Filed:
Sep 21, 1993
Appl. No.:
08/125065
Inventors:
Edward T. Cox - Foster City CA
Jennie P. Mather - Millbrae CA
Mary B. Sliwkowski - San Carlos CA
Teresa K. Woodruff - Millbrae CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
G01N 3353
US Classification:
435 71, 435 72, 436501
Abstract:
An isolated TGF- supergene family (TSF) receptor polypeptide is provided. This polypeptide preferably is an inhibin/activin receptor polypeptide and has at least 75% sequence identity with the mature human inhibin/activin receptor sequence. Also provided is a method for purifying TGF- supergene family members such as inhibin or activin using the polypeptide, and a method for screening for compounds with TGF- supergene family member activity by contacting the compound with the polypeptide and detecting if binding has occurred and the compound is active.

Secreted And Transmembrane Polypeptides And Nucleic Acids Encoding The Same

US Patent:
6635468, Oct 21, 2003
Filed:
Jul 17, 2001
Appl. No.:
09/907794
Inventors:
Avi Ashkenazi - San Mateo CA
David Botstein - Belmont CA
Luc Desnoyers - San Francisco CA
Dan L. Eaton - San Rafael CA
Napoleone Ferrara - San Francisco CA
Ellen Filvaroff - San Francisco CA
Sherman Fong - Alameda CA
Wei-Qiang Gao - Palo Alto CA
Hanspeter Gerber - San Francisco CA
Mary E. Gerritsen - San Mateo CA
Audrey Goddard - San Francisco CA
Paul J. Godowski - Hillsborough CA
J. Christopher Grimaldi - San Francisco CA
Austin L. Gurney - Belmont CA
Kenneth J. Hillan - San Francisco CA
Ivar J. Kljavin - Pacifica CA
Jennie P. Mather - Millbrae CA
James Pan - Zitobicoke, CA
Nicholas F. Paoni - Granger IN
Margaret Ann Roy - San Francisco CA
Timothy A. Stewart - San Francisco CA
Daniel Tumas - Orinda CA
P. Mickey Williams - Half Moon Bay CA
William I. Wood - Hillsborough CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C12N 121
US Classification:
4352523, 435 691, 43525411, 435325, 4353201, 536 231, 536 235, 536 241
Abstract:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Use Of Leukemia Inhibitory Factor And Endothelin Antagonists

US Patent:
6653287, Nov 25, 2003
Filed:
Sep 13, 2000
Appl. No.:
09/660590
Inventors:
Napoleone Ferrara - San Francisco CA
Kathleen King - Pacifica CA
Elizabeth Luis - San Francisco CA
Jennie P. Mather - Millbrae CA
Nicholas F. Paoni - Belmont CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 3817
US Classification:
514 21, 514 2, 530300, 530350
Abstract:
A leukemia inhibitory factor antagonist, alone or in combination with an endothelin antagonist, may be used for treatment of heart failure. The antagonist(s) are administered in a chronic fashion, in therapeutically effective amounts, to achieve this purpose.

Secreted And Transmembrane Polypeptides And Nucleic Acids Encoding The Same

US Patent:
6664376, Dec 16, 2003
Filed:
Jul 12, 2001
Appl. No.:
09/905125
Inventors:
Avi Ashkenazi - San Mateo CA
David Botstein - Belmont CA
Luc Desnoyers - San Francisco CA
Dan L. Eaton - San Rafael CA
Napoleone Ferrara - San Francisco CA
Ellen Filvaroff - San Francisco CA
Sherman Fong - Alameda CA
Wei-Qiang Gao - Palo Alto CA
Hanspeter Gerber - San Francisco CA
Mary E. Gerritsen - San Mateo CA
Audrey Goddard - San Francisco CA
Paul J. Godowski - Hillsborough CA
J. Christopher Grimaldi - San Francisco CA
Austin L. Gurney - Belmont CA
Kenneth J. Hillan - San Francisco CA
Ivar J. Kljavin - Pacifica CA
Jennie P. Mather - Millbrae CA
James Pan - Zitobicoke, CA
Nicholas F. Paoni - Granger IN
Margaret Ann Roy - San Francisco CA
Timothy A. Stewart - San Francisco CA
Daniel Tumas - Orinda CA
P. Mickey Williams - Half Moon Bay CA
William I. Wood - Hillsborough CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 14435
US Classification:
530350, 435219
Abstract:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Control profile
Jennie Powell Mather from Millbrae, CA, age ~76 Get Report